Investor Announcements - 2018
|
| ||
Shareholder approval was received for a distribution in specie of shares in Renalytix AI plc to the Company's shareholders. | ||
| ||
EKF Diagnostics announces the resolution from the General Meeting held earlier today. | ||
| ||
EKF Diagnostics announces a briefing for all investors to provide details of the successful fundraising and proposed AIM admission of Renalytix AI plc. | ||
| ||
Today the Company announced a successful, conditional equity fundraising by its spin-out business, Renalytix AI plc. | ||
| ||
EKF Diagnostics confirms equity fundraising. | ||
| ||
EKF Diagnostics Holdings plc announces that a general meeting of the Company will be held on 19 October 2018. | ||
| ||
EKF Diagnostics Holdings plc announces its unaudited interim results for the six months ended 30 June 2018. | ||
| ||
EKF Diagnostics Holdings plc announces that it will release its interim results for the six months ended 30 June 2018 on Wednesday 19 September 2018. | ||
| ||
EKF to undertake further market soundings ahead of a prospective equity Fundraising by Renalytix AI and the admission of its shares to trading on AIM. | ||
| ||
Standard form for notification of major holdings. | ||
| |||||||
Newsletter
Keep up to date with all our activities, events, exhibitions, promotions, investor news & more.